Related Experiment Video
Updated: Mar 31, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Venture Capital Investment in the Life Sciences in Switzerland
1BioMedPartners AG Elisabethenstrasse 23 CH-4051 Basel, Switzerland. hosang@biomedvc.com.
Abstract:
Innovation is one of the main driving factors for continuous and healthy economic growth and welfare. Switzerland as a resource-poor country is particularly dependent on innovation, and the life sciences, which comprise biotechnologies, (bio)pharmaceuticals, medical technologies and diagnostics, are one of the key areas of innovative strength of Switzerland. Venture capital financing and venture capitalists (frequently called 'VCs') and investors in public equities have played and still play a pivotal role in financing the Swiss biotechnology industry. In the following some general features of venture capital investment in life sciences as well as some opportunities and challenges which venture capital investors in Switzerland are facing are highlighted. In addition certain means to counteract these challenges including the 'Zukunftsfonds Schweiz' are discussed.
Related Concept Videos
Production of Pharmaceuticals
Preclinical Development: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

